UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013823
Receipt number R000016025
Scientific Title Effect of preoperative steroids administration in laparoscopic hepatectomy with pedicle clamping: a prospective randomized study
Date of disclosure of the study information 2014/04/28
Last modified on 2019/11/20 21:55:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of preoperative steroids administration in laparoscopic hepatectomy with pedicle clamping: a prospective randomized study

Acronym

RCT to evaluate steroids administration in laparoscopic hepatectomy with pedicle clamping

Scientific Title

Effect of preoperative steroids administration in laparoscopic hepatectomy with pedicle clamping: a prospective randomized study

Scientific Title:Acronym

RCT to evaluate steroids administration in laparoscopic hepatectomy with pedicle clamping

Region

Japan


Condition

Condition

Diseases planned to undergo laparoscopic liver resection(malignant/benign tumor, benign diseases)

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

There is no consensus on the beneficial effects of preoperative steroid administrations in patients undergoing laparoscopic hepatectomy with pedicle clamping. The aim of this prospective randomized controlled study is to investigate the clinical benefits of preoperative steroid administration.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Serum total bilirubin level

Key secondary outcomes

Serum AST, ALT, PPT-INR, CRP,and IL-6 levels . Postoperative complications and length of hospital stay.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

The patients are assigned randomly to a control group or a steroid group in which patients received 500mg of methylprednisolone at induction.

Interventions/Control_2

Administration only saline solution.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who were planned to undergo pure laparoscopic liver resection, and their performance status were 0 or 1.

Key exclusion criteria

Difficult to undergo a surgery under general anesthesia. Patients with active infection, with uncontrollable diabetes mellitus, in pregnancy, or under 20-year-old.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Seiichiro
Middle name
Last name Kobayashi

Organization

Iwate Medical University School of Medicine

Division name

Department of Surgery

Zip code

0208505

Address

Uchimaru 19-1, Morioka city, Iwate

TEL

019-651-5111

Email

mdean@iwate-med.ac.jp


Public contact

Name of contact person

1st name Yasushi
Middle name
Last name Hasegawa

Organization

Iwate Medical University School of Medicine

Division name

Department of Surgery

Zip code

0208505

Address

Uchimaru 19-1, Morioka city, Iwate

TEL

019-651-5111

Homepage URL


Email

hasegawayas@yahoo.co.jp


Sponsor or person

Institute

Department of Surgery, Iwate Medical University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Iwate medical university school of medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Iwate Medical University School of Medicine

Address

Uchimaru 19-1, Morioka city, Iwate

Tel

019-651-5111

Email

ikyomu@j.iwate-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 28 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

130

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 04 Month 10 Day

Date of IRB

2014 Year 03 Month 19 Day

Anticipated trial start date

2014 Year 04 Month 30 Day

Last follow-up date

2019 Year 01 Month 10 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2019 Year 02 Month 28 Day


Other

Other related information



Management information

Registered date

2014 Year 04 Month 28 Day

Last modified on

2019 Year 11 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016025


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name